Who is sponsoring NCT06032286?

NCT06032286 is sponsored by Beauty Health.

What drugs are being tested in NCT06032286?

Interventions in NCT06032286: Skinstylus microneedling device.

What condition does NCT06032286 study?

NCT06032286 studies Subjects Displaying Facial Ageing.

Is NCT06032286 still recruiting?

NCT06032286 is currently completed. Last updated 7 August 2024.

Last reviewed 2024-08-07 · How we verify

NCT06032286

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Efficacy and Safety of the Skinstylus Sterilock Microneedling System for the Treatment of Facial Wrinkles

Completed NA Last updated 7 August 2024

What this trial tests

NA trial testing Skinstylus microneedling device in Subjects Displaying Facial Ageing in 51 participants. Completed in 9 May 2024.

Timeline

8 September 2023

Primary endpoint
9 May 2024

9 May 2024

Quick facts

Lead sponsor	Beauty Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	51
Start date	8 September 2023
Primary completion	9 May 2024
Estimated completion	9 May 2024
Sites	2 locations across United States

Drugs / interventions tested

Skinstylus microneedling device

Conditions studied

Subjects Displaying Facial Ageing — all drugs for Subjects Displaying Facial Ageing →

Sponsor

Beauty Health

Who can join

Adults 35 to 75, any sex, with Subjects Displaying Facial Ageing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the efficacy and safety of the Skin stylus Sterilock microneedling system in reducing the appearance of facial wrinkles.This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 4 microneedling sessions at baseline and days 30, 60 and 90. Subjects will be assessed at days 90, 120 and finally at day 150 by a physician utilizing the wrinkle grading scale developed by Lemperle (2001) and skin laxity and texture using a modified Alexiandes Armenakas (2010) grading scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Beauty Health trials

Trials by the same sponsor.

NCT06112782 — Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06032286 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beauty Health
Last refreshed: 7 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06032286.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing